Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol ALOX5 contributors: mct - updated : 07-06-2018
HGNC name arachidonate 5-lipoxygenase
HGNC id 435
RNA
TRANSCRIPTS type messenger
identificationnb exonstypebpproduct
ProteinkDaAAspecific expressionYearPubmed
14 - 2568 - 674 - Assimes (2008)
EXPRESSION
Type widely
   expressed in (based on citations)
organ(s)
SystemOrgan level 1Organ level 2Organ level 3Organ level 4LevelPubmedSpeciesStageRna symbol
Lymphoid/Immunelymph node   highly
 tonsils   highly
tissue
SystemTissueTissue level 1Tissue level 2LevelPubmedSpeciesStageRna symbol
Blood / hematopoieticbone marrow  highly
cells
SystemCellPubmedSpeciesStageRna symbol
Lymphoid/Immunemacrophage
cell lineage
cell lines
fluid/secretion
at STAGE
PROTEIN
PHYSICAL PROPERTIES
STRUCTURE
motifs/domains
  • PLAT/LH2 domain
  • N terminal lipoxigenase homology 2 (beta barrel) domain (residues 1–114)
  • C2-like domain, a genuine Ca(2+)-dependent membrane-targeting domain, for the specific targeting to the nuclear envelope
  • a C-terminal catalytic domain (residues 121–673)(Radmark 2010)
  • secondary structure catalytic domain, composed of several alpha-helices, binds the prosthetic iron (Radmark 2010)
    mono polymer monomer
    HOMOLOGY
    interspecies homolog to murine Alox5
    Homologene
    FAMILY
  • lipoxigenase family
  • CATEGORY enzyme , immunity/defense
    SUBCELLULAR LOCALIZATION     intracellular
    intracellular,cytoplasm
    intracellular,nucleus
    intracellular,nuclear envelope
    text activation involves its calcium-dependent translocation to the nuclear envelope
    basic FUNCTION
  • catalyzing the first step of leukotrienes biosynthesis from arachidonate
  • lipid peroxidating enzyme implicated in the pathogenesis of inflammatory disorders as well as membrane remodeling
  • carcinogenesis, atheroma and asthma
  • catalyzes two steps in the biosynthesis of leukotrienes (LTs), lipid mediators of inflammation derived from arachidonic acid (Radmark 2010)
  • CELLULAR PROCESS
    PHYSIOLOGICAL PROCESS inflammation
    PATHWAY
    metabolism lipid/lipoprotein
    signaling
    a component
    INTERACTION
    DNA
    RNA
    small molecule metal binding,
  • iron Fe2+
  • protein
  • interacting with COTL1 (binds ALOX5 and promotes leukotrienes formation) (Esser 2009)
  • cell & other
    REGULATION
    activated by binding ALOX5AP and translocated to plasma membrane
    ASSOCIATED DISORDERS
    corresponding disease(s)
    Other morbid association(s)
    TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
    tumoral     --over  
    in prostate cancer with poor prognosis
    Susceptibility to atherosclerosis
    Variant & Polymorphism other increasing the risk of atheroscleosis
    Candidate gene
    Marker
  • dysregulated levels of ALOX5 may be involved in sepsis pathophysiology and may be utilized as potential diagnostic biomarkers
  • Therapy target
    SystemTypeDisorderPubmed
    digestiveliver 
    melatonin directly suppresses hepatic stellate cells (HSC) activation via RORA-mediated inhibition of ALOX5 expression, which provides novel drug targets to treat liver fibrosis
    cancerhemopathy 
    removing and inhibiting ALOX5, prompting us to test this novel therapeutic strategy in human individuals with CML in the future
    ANIMAL & CELL MODELS